Activation of beta3-AR with mirabegron in hypertrophic cardiomyopathy: the BETA3LVH trial.
28 August 2022 (16:45 - 17:00)
Organised by:
Slides
About the speaker

University hospital Leipzig AoR, Leipzig (Germany)
3 More presentations in this session


Doctor A. Garcia-Alvarez (Barcelona, ES)

Doctor M. Gray (St Leonards, US)
Access the full session
The Event
ESC Congress 2022
28 August 2022
16:45 CET
You may be interested in
Congress Session
Congress Presentation


